MAPK signaling in cisplatin-induced death: predominant role of ERK1 over ERK2 in human hepatocellular carcinoma cells.
about
Integrative analysis of high-throughput RNAi screen data identifies the FER and CRKL tyrosine kinases as new regulators of the mitogenic ERK-dependent pathways in transformed cellsERK1 and ERK2 Map Kinases: Specific Roles or Functional Redundancy?Screening of potential biomarkers for chemoresistant ovarian carcinoma with miRNA expression profiling data by bioinformatics approach.Growth arrest signaling of the Raf/MEK/ERK pathway in cancer.Cannabidiol protects liver from binge alcohol-induced steatosis by mechanisms including inhibition of oxidative stress and increase in autophagy.Extracellular signal-regulated kinase 1 and 2 in cancer therapy: a focus on hepatocellular carcinoma.Butein sensitizes HeLa cells to cisplatin through the AKT and ERK/p38 MAPK pathways by targeting FoxO3a.Twist2 promotes self-renewal of liver cancer stem-like cells by regulating CD24.The RAF-MEK-ERK pathway: targeting ERK to overcome obstacles to effective cancer therapy.Increasing 3D Matrix Rigidity Strengthens Proliferation and Spheroid Development of Human Liver Cells in a Constant Growth Factor Environment.Oncogenic KRAS sensitizes premalignant, but not malignant cells, to Noxa-dependent apoptosis through the activation of the MEK/ERK pathway.Noxa couples lysosomal membrane permeabilization and apoptosis during oxidative stress.The pathogenesis of diclofenac induced immunoallergic hepatitis in a canine model of liver injury.Involvement of Src signaling in the synergistic effect between cisplatin and digoxin on cancer cell viability.p53-independent Noxa induction by cisplatin is regulated by ATF3/ATF4 in head and neck squamous cell carcinoma cells.ERK1 Directly Interacts With JNK1 Leading to Regulation of JNK1/c-Jun Activity and Cell Transformation.MEK1/2 overactivation can promote growth arrest by mediating ERK1/2-dependent phosphorylation of p70S6K.
P2860
Q24311542-A1052668-7626-4B2C-B3A8-D9F92CD57291Q26744787-013C0B11-F4EA-467C-B5A5-7BC70856C75BQ31029533-0304F3C6-CA62-4441-B177-3835FBACF2AAQ33836237-CF55C74D-C03E-4EA4-950B-2ADE943FA056Q33959167-9F0BADD2-5540-42B1-9433-5C905EDF1CD5Q35894374-04851E33-3037-4472-A8C4-F6EDBE2EC310Q36041749-D07561E5-6EBD-454A-8B26-A92657ADCDB9Q38311444-4D3FD2CE-C52B-452F-8BFE-4C98486278DBQ38397326-CA07D4AD-C3EC-4F73-8A83-FCC7B280E11EQ38838612-CBB1C889-11DB-4866-B744-7CF2FF033DA0Q41627000-5D4D2C89-6732-4229-818D-300144A0E080Q41820954-27F4B6DB-8EA3-42C8-8D4A-DE1CD84D8D35Q47159298-9E265AAB-1DDC-4595-A387-BFD10C91904CQ47843690-8AEF810F-FCB9-41EA-88DC-4C00D6C25309Q49907165-BA6BF96D-9F14-48B6-B637-404A80BD9E73Q51179467-93D00DDC-8BE4-4245-B865-F8F9D1BBCFEBQ53067804-76A32145-F5E5-4A4B-9665-267F169FC365
P2860
MAPK signaling in cisplatin-induced death: predominant role of ERK1 over ERK2 in human hepatocellular carcinoma cells.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh
2012年學術文章
@zh-hant
name
MAPK signaling in cisplatin-in ...... epatocellular carcinoma cells.
@en
MAPK signaling in cisplatin-in ...... epatocellular carcinoma cells.
@nl
type
label
MAPK signaling in cisplatin-in ...... epatocellular carcinoma cells.
@en
MAPK signaling in cisplatin-in ...... epatocellular carcinoma cells.
@nl
prefLabel
MAPK signaling in cisplatin-in ...... epatocellular carcinoma cells.
@en
MAPK signaling in cisplatin-in ...... epatocellular carcinoma cells.
@nl
P2093
P2860
P356
P1433
P1476
MAPK signaling in cisplatin-in ...... epatocellular carcinoma cells.
@en
P2093
Frédéric Ezan
Georges Baffet
Jean-Philippe Guégan
Sophie Langouët
P2860
P356
10.1093/CARCIN/BGS317
P407
P577
2012-10-05T00:00:00Z